TONI MCFADDEN: Open Payments
NPI 1205859311 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 27 payments from 15 companies in 2025. Trend: 2023 $382 · 2024 $513 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $237 |
| Merck Sharp & Dohme LLC | 4 | $109 |
| PFIZER INC. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| United Therapeutics Corporation | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Amgen Inc. | 1 | $29 |
Products named: WATCHMAN FLX, WINREVAIR, VYNDAQEL, LEQVIO, Tyvaso, VERQUVO, ONPATTRO, UPTRAVI.
Industry payments across CA — which companies pay providers there.
